GAMMA-Aminobutyric acid, or y-aminobutyric acid or GABA, is the chief inhibitory neurotransmitter in the mammalian central nervous system. Its principal role is reducing neuronal excitability throughout the nervous system. The report focuses on the GABA (Gamma-Aminobutyric Acid) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the GABA (Gamma-Aminobutyric Acid) market. Major Players in the GABA (Gamma-Aminobutyric Acid) market are: Sanofi Elan Glaxosmithkline Novartis Ovation Pharmaceuticals Astrazeneca Eli Lilly Pfizer Vivus On the basis of types, the GABA (Gamma-Aminobutyric Acid) market is primarily split into: Chemical Synthesis Biological Fermentation On the basis of applications, the market covers: Pharmaceuticals Foods Beverages Feeds Industries Major Regions or countries covered in this report: United States Europe China Japan India Southeast Asia Latin America Middle East and Africa Others Years considered for this report: Historical Years: 2017-2021 Base Year: 2021 Estimated Year: 2022 Forecast Period: 2022-2029
Table of Content 1 GABA (Gamma-Aminobutyric Acid) Market Overview 1.1 Product Overview and Scope of GABA (Gamma-Aminobutyric Acid) Market 1.2 GABA (Gamma-Aminobutyric Acid) Market Segment by Type 1.2.1 Global GABA (Gamma-Aminobutyric Acid) Market Sales and CAGR (%) Comparison by Type (2017-2029) 1.3 Global GABA (Gamma-Aminobutyric Acid) Market Segment by Application 1.3.1 GABA (Gamma-Aminobutyric
